Sprint Bioscience AB banner
S

Sprint Bioscience AB
STO:SPRINT

Watchlist Manager
Sprint Bioscience AB
STO:SPRINT
Watchlist
Price: 1.86 SEK -2.62% Market Closed
Market Cap: kr196.3m

Cash Flow Statement

Cash Flow Statement
Sprint Bioscience AB

Rotate your device to view
Cash Flow Statement
Currency: SEK
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Operating Cash Flow
Net Income
(7)
(9)
(9)
(11)
(13)
(15)
(15)
(15)
(14)
(5)
(2)
5
8
5
(1)
(11)
(4)
(15)
(18)
(22)
(36)
(21)
(21)
(20)
(23)
(38)
(35)
(38)
(41)
(46)
(24)
(26)
(27)
(30)
(61)
(61)
(59)
(52)
(10)
(1)
8
14
(20)
(20)
(21)
(22)
(25)
97
Depreciation & Amortization
0
0
0
1
1
0
0
0
0
0
3
3
3
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
1
1
1
1
1
1
1
1
Other Non-Cash Items
0
0
0
0
0
0
0
0
0
3
0
0
1
(2)
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
1
1
1
2
3
4
5
2
1
0
(1)
0
0
0
0
0
0
0
0
0
1
0
0
1
1
6
Change in Working Capital
0
3
0
(0)
1
0
16
16
13
2
7
(0)
(6)
(1)
(19)
(13)
(3)
2
(2)
2
(8)
(22)
(5)
(8)
10
20
(1)
5
(6)
(15)
(10)
(15)
(14)
2
2
1
10
8
20
23
8
9
(1)
(5)
0
(8)
(14)
(15)
Cash from Operating Activities
(6)
N/A
(6)
0%
(8)
-28%
(11)
-36%
(11)
-5%
(14)
-28%
2
N/A
1
-55%
(1)
N/A
0
N/A
9
+2 314%
8
-9%
7
-15%
6
-15%
(19)
N/A
(23)
-21%
(7)
+72%
(12)
-84%
(20)
-66%
(19)
+4%
(43)
-126%
(43)
+1%
(25)
+42%
(28)
-13%
(12)
+55%
(18)
-41%
(35)
-102%
(32)
+9%
(47)
-47%
(61)
-28%
(33)
+45%
(40)
-20%
(41)
-1%
(28)
+31%
(59)
-109%
(59)
0%
(48)
+19%
(44)
+8%
10
N/A
23
+120%
16
-31%
24
+51%
(20)
N/A
(23)
-17%
(20)
+16%
(29)
-47%
(38)
-33%
84
N/A
Investing Cash Flow
Capital Expenditures
(5)
(3)
(3)
(4)
(5)
(5)
(6)
(6)
(6)
(8)
(9)
(10)
(11)
(11)
(10)
(9)
(8)
(9)
(10)
(11)
(9)
(5)
(2)
(0)
0
0
0
0
(1)
(1)
(3)
(3)
(2)
(2)
(0)
0
0
0
0
(2)
(3)
(3)
(3)
(1)
(1)
(1)
(1)
(0)
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
(5)
N/A
(3)
+31%
(3)
+1%
(4)
-18%
(5)
-24%
(5)
-8%
(6)
-9%
(6)
-5%
(6)
-1%
(8)
-29%
(9)
-16%
(10)
-6%
(11)
-10%
(11)
0%
(10)
+8%
(9)
+15%
(8)
+8%
(9)
-11%
(10)
-20%
(11)
-6%
(9)
+18%
(5)
+41%
(2)
+61%
(0)
+81%
(0)
+39%
(0)
-5%
(0)
N/A
0
N/A
(1)
N/A
(1)
-28%
(3)
-149%
(3)
0%
(2)
+31%
(2)
+13%
(0)
+100%
0
N/A
0
N/A
0
N/A
0
N/A
(2)
N/A
(3)
-31%
(3)
+0%
(3)
0%
(1)
+60%
(1)
+56%
(1)
0%
(1)
+0%
(0)
+91%
Financing Cash Flow
Net Issuance of Common Stock
9
13
11
28
26
20
20
0
18
18
18
19
0
0
0
10
10
48
48
38
64
26
26
36
10
10
59
49
49
80
89
89
0
58
0
18
18
18
18
0
0
(0)
(0)
(0)
(0)
23
23
18
Net Issuance of Debt
2
0
0
(0)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
12
0
0
0
(12)
0
10
10
10
10
(10)
10
10
10
20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(5)
(6)
(7)
(7)
(2)
(1)
(1)
(2)
(1)
(5)
(9)
(8)
(8)
(5)
(12)
(12)
0
0
0
0
0
0
0
0
0
0
0
0
0
(5)
(5)
0
Cash from Financing Activities
11
N/A
13
+13%
11
-11%
28
+151%
25
-10%
19
-25%
19
+2%
(1)
N/A
18
N/A
18
N/A
17
-3%
18
+4%
(1)
N/A
(1)
-1%
(1)
+1%
9
N/A
4
-54%
41
+833%
41
+0%
43
+5%
62
+42%
25
-59%
25
+0%
22
-13%
9
-59%
15
+64%
60
+304%
51
-15%
51
+1%
65
+27%
86
+33%
86
N/A
86
0%
67
-23%
0
N/A
18
N/A
18
N/A
18
+0%
18
N/A
0
-100%
0
N/A
(0)
N/A
(0)
N/A
(0)
N/A
(0)
N/A
18
N/A
18
+1%
18
0%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
0
0
0
Net Change in Cash
0
N/A
3
+15 050%
(0)
N/A
13
N/A
9
-32%
(1)
N/A
15
N/A
(6)
N/A
10
N/A
10
-2%
16
+67%
16
-1%
(5)
N/A
(6)
-23%
(30)
-404%
(22)
+25%
(10)
+55%
21
N/A
11
-47%
13
+21%
9
-28%
(23)
N/A
(2)
+93%
(6)
-281%
(4)
+42%
(3)
+19%
24
N/A
19
-23%
3
-83%
3
+2%
50
+1 470%
44
-13%
44
+0%
37
-16%
(59)
N/A
(41)
+30%
(30)
+28%
(26)
+13%
28
N/A
20
-28%
13
-38%
21
+62%
(23)
N/A
(25)
-7%
(21)
+15%
(11)
+46%
(21)
-83%
102
N/A
Free Cash Flow
Free Cash Flow
(11)
N/A
(10)
+14%
(11)
-18%
(15)
-31%
(16)
-10%
(20)
-22%
(4)
+80%
(5)
-33%
(8)
-42%
(8)
-2%
(1)
+91%
(2)
-186%
(4)
-113%
(5)
-25%
(29)
-455%
(32)
-9%
(14)
+55%
(21)
-44%
(30)
-46%
(30)
+1%
(52)
-73%
(48)
+8%
(27)
+44%
(28)
-4%
(12)
+56%
(18)
-41%
(35)
-102%
(32)
+9%
(48)
-49%
(62)
-28%
(36)
+42%
(43)
-19%
(42)
+1%
(30)
+30%
(59)
-98%
(59)
0%
(48)
+19%
(44)
+8%
10
N/A
20
+96%
13
-38%
21
+64%
(23)
N/A
(25)
-7%
(20)
+18%
(29)
-46%
(39)
-33%
83
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett